Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
Recruiting
N/A
Interventional Study
Autism Spectrum Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 7 – 26
- Sex
- Any
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 20 (estimated)
- Sponsor
- Neuropix · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written informed consent
* Age: between 7 and 26 years
* Participants and parent/ guardian must have proficiency in English
* Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria
Exclusion Criteria:
* Severe psychiatric disorders (e.g. bipolar, major depressive disorder)
…
Contacts